Literature DB >> 6771137

The clinical comparison of skeletal imaging agents.

F G Adams, P W Horton, G Stenhouse.   

Abstract

99-MTc-methylene diophosphonate from two manufacturers was compared with 99mTc-ethane hydroxy diphosphonate in a randomised trial to assess the relative blood clearances and the subsequent image quality. The 99mTc-methylene diphosphonate preparations were found to be superior with respect to both blood clearance and subjectively assessed image quality, particularly when the interval between injection and scanning was three hours. Bone/soft tissue ratios did not mirror the highly significant qualitative comparisons of image quality.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6771137     DOI： 10.1007/bf00271908

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  4 in total

1.  A comparison of phosphate bone-scanning agents in normal subjects and patients with malignant disease.

Authors:  D L Citrin; R G Bessent; J B Tuohy; S T elms; E McGinlay; W R Greig; L Blumgart
Journal:  Br J Radiol       Date:  1975-02       Impact factor: 3.039

2.  A new complex of 99mTc for skeletal imaging.

Authors:  G Subramanian; J G McAfee
Journal:  Radiology       Date:  1971-04       Impact factor: 11.105

3.  Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.

Authors:  G Subramanian; J G McAfee; R J Blair; F A Kallfelz; F D Thomas
Journal:  J Nucl Med       Date:  1975-08       Impact factor: 10.057

4.  Tc-99m methylene diphosphonate versus Tc-99m pyrophosphate: biologic and clinical comparison.

Authors:  T G Rudd; D R Allen; D E Hartnett
Journal:  J Nucl Med       Date:  1977-09       Impact factor: 10.057
  4 in total
  1 in total

1.  Factors influencing bone scan quality.

Authors:  F G Adams; A W Shirley
Journal:  Eur J Nucl Med       Date:  1983
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.